Annual CAPEX
$194.00 K
-$60.00 K-23.62%
December 31, 2023
Summary
- As of March 2, 2025, URGN annual capital expenditures is $194.00 thousand, with the most recent change of -$60.00 thousand (-23.62%) on December 31, 2023.
- During the last 3 years, URGN annual CAPEX has fallen by -$1.02 million (-84.03%).
- URGN annual CAPEX is now -84.03% below its all-time high of $1.22 million, reached on December 31, 2020.
Performance
URGN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$96.00 K
+$12.00 K+14.29%
September 30, 2024
Summary
- As of March 2, 2025, URGN quarterly capital expenditures is $96.00 thousand, with the most recent change of +$12.00 thousand (+14.29%) on September 30, 2024.
- Over the past year, URGN quarterly CAPEX has dropped by -$4000.00 (-4.00%).
- URGN quarterly CAPEX is now -85.45% below its all-time high of $660.00 thousand, reached on September 30, 2020.
Performance
URGN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$236.00 K
-$4000.00-1.67%
September 30, 2024
Summary
- As of March 2, 2025, URGN TTM capital expenditures is $236.00 thousand, with the most recent change of -$4000.00 (-1.67%) on September 30, 2024.
- Over the past year, URGN TTM CAPEX has increased by +$85.00 thousand (+56.29%).
- URGN TTM CAPEX is now -83.21% below its all-time high of $1.41 million, reached on March 31, 2021.
Performance
URGN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
URGN CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.6% | -4.0% | +56.3% |
| 3 y3 years | -84.0% | -50.5% | -67.3% |
| 5 y5 years | -65.4% | +95.9% | -27.4% |
URGN CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.2% | at low | -52.5% | +638.5% | -68.6% | +56.3% |
| 5 y | 5-year | -84.0% | at low | -85.5% | +638.5% | -83.2% | +56.3% |
| alltime | all time | -84.0% | at low | -85.5% | +638.5% | -83.2% | +202.6% |
UroGen Pharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $96.00 K(+14.3%) | $236.00 K(-1.7%) |
| Jun 2024 | - | $84.00 K(+50.0%) | $240.00 K(+23.7%) |
| Dec 2023 | $194.00 K(-23.6%) | $56.00 K(-44.0%) | $194.00 K(+28.5%) |
| Sep 2023 | - | $100.00 K(+566.7%) | $151.00 K(-26.0%) |
| Jun 2023 | - | $15.00 K(-34.8%) | $204.00 K(-19.0%) |
| Mar 2023 | - | $23.00 K(+76.9%) | $252.00 K(-0.8%) |
| Dec 2022 | $254.00 K(-66.2%) | $13.00 K(-91.5%) | $254.00 K(-42.7%) |
| Sep 2022 | - | $153.00 K(+142.9%) | $443.00 K(-8.5%) |
| Jun 2022 | - | $63.00 K(+152.0%) | $484.00 K(-1.2%) |
| Mar 2022 | - | $25.00 K(-87.6%) | $490.00 K(-34.8%) |
| Dec 2021 | $752.00 K(-38.1%) | $202.00 K(+4.1%) | $752.00 K(+4.2%) |
| Sep 2021 | - | $194.00 K(+181.2%) | $722.00 K(-39.2%) |
| Jun 2021 | - | $69.00 K(-76.0%) | $1.19 M(-15.5%) |
| Mar 2021 | - | $287.00 K(+66.9%) | $1.41 M(+15.7%) |
| Dec 2020 | $1.22 M | $172.00 K(-73.9%) | $1.22 M(-1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $660.00 K(+130.0%) | $1.24 M(+97.9%) |
| Jun 2020 | - | $287.00 K(+199.0%) | $624.00 K(+65.5%) |
| Mar 2020 | - | $96.00 K(-50.0%) | $377.00 K(+16.0%) |
| Dec 2019 | $325.00 K(-42.0%) | $192.00 K(+291.8%) | $325.00 K(+107.0%) |
| Sep 2019 | - | $49.00 K(+22.5%) | $157.00 K(-64.3%) |
| Jun 2019 | - | $40.00 K(-9.1%) | $440.00 K(-17.3%) |
| Mar 2019 | - | $44.00 K(+83.3%) | $532.00 K(-5.0%) |
| Dec 2018 | $560.00 K(+106.6%) | $24.00 K(-92.8%) | $560.00 K(-18.7%) |
| Sep 2018 | - | $332.00 K(+151.5%) | $689.00 K(+82.8%) |
| Jun 2018 | - | $132.00 K(+83.3%) | $377.00 K(+42.3%) |
| Mar 2018 | - | $72.00 K(-52.9%) | $265.00 K(-2.2%) |
| Dec 2017 | $271.00 K(-61.0%) | $153.00 K(+665.0%) | $271.00 K(+129.7%) |
| Sep 2017 | - | $20.00 K(0.0%) | $118.00 K(+20.4%) |
| Jun 2017 | - | $20.00 K(-74.4%) | $98.00 K(+25.6%) |
| Mar 2017 | - | $78.00 K | $78.00 K |
| Dec 2016 | $695.00 K | - | - |
FAQ
- What is UroGen Pharma annual capital expenditures?
- What is the all time high annual CAPEX for UroGen Pharma?
- What is UroGen Pharma annual CAPEX year-on-year change?
- What is UroGen Pharma quarterly capital expenditures?
- What is the all time high quarterly CAPEX for UroGen Pharma?
- What is UroGen Pharma quarterly CAPEX year-on-year change?
- What is UroGen Pharma TTM capital expenditures?
- What is the all time high TTM CAPEX for UroGen Pharma?
- What is UroGen Pharma TTM CAPEX year-on-year change?
What is UroGen Pharma annual capital expenditures?
The current annual CAPEX of URGN is $194.00 K
What is the all time high annual CAPEX for UroGen Pharma?
UroGen Pharma all-time high annual capital expenditures is $1.22 M
What is UroGen Pharma annual CAPEX year-on-year change?
Over the past year, URGN annual capital expenditures has changed by -$60.00 K (-23.62%)
What is UroGen Pharma quarterly capital expenditures?
The current quarterly CAPEX of URGN is $96.00 K
What is the all time high quarterly CAPEX for UroGen Pharma?
UroGen Pharma all-time high quarterly capital expenditures is $660.00 K
What is UroGen Pharma quarterly CAPEX year-on-year change?
Over the past year, URGN quarterly capital expenditures has changed by -$4000.00 (-4.00%)
What is UroGen Pharma TTM capital expenditures?
The current TTM CAPEX of URGN is $236.00 K
What is the all time high TTM CAPEX for UroGen Pharma?
UroGen Pharma all-time high TTM capital expenditures is $1.41 M
What is UroGen Pharma TTM CAPEX year-on-year change?
Over the past year, URGN TTM capital expenditures has changed by +$85.00 K (+56.29%)